Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
What insulin pump features and settings do you utilize in patients with diabetes and end stage renal disease on intermittent hemodialysis or home peritoneal dialysis?
Related Questions
How do you manage a painful nodule that is presumably due to fat necrosis at an insulin injection site?
Do you favor Sotagliflozin over SGLT2i alone for cardiovascular risk reduction in patients with Type 2 diabetes and chronic kidney disease?
In patients using a tandem insulin pump on auto-mode/Control-IQ, would decreasing the basal settings on the profile actually reduce the delivered hourly insulin dose or is that only relevant if they switch to manual mode?
How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?
Do you recommend using intermediate-acting insulin over long-acting insulin for the management of steroid-induced hyperglycemia?
Is the accuracy of continuous glucose monitors (DEXCOM or Libre) lower in patients undergoing dialysis?
Is the combination of SGLT2i and GLP 1 R agonist therapy contraindicated in patients who develop an episode of euglycemic DKA?
How do you recommend adjusting insulin pump settings when transitioning from U-100 to U-200 Humalog insulin?
How do you approach adjusting insulin pump settings in patients who have received intra-articular corticosteroid injections?
Would you start once-weekly tirzepatide over once daily basal insulin in a patient with Type 2 diabetes with inadequate control on oral antihyperglycemia drugs?
